Efficacy and Safety of Everolimus (RAD001) in Patients With Advanced Gastric Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of everolimus 10mg daily in
patients with advanced gastric carcinoma (inoperable, recurrent or metastatic gastric cancer)
whose cancer has progressed despite prior treatment.